Taichi Matsubara
Overview
Explore the profile of Taichi Matsubara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akamine T, Wakasu S, Matsubara T, Yamaguchi M, Yamazaki K, Hamatake M, et al.
Ann Surg Oncol
. 2025 Jan;
PMID: 39871081
No abstract available.
2.
Takamori S, Endo M, Hamada A, Ohara S, Fukuda S, Tomioka Y, et al.
Clin Lung Cancer
. 2025 Jan;
PMID: 39824660
Background: While Epidermal growth factor receptor (EGFR) mutation-positive lung adenocarcinoma (LUAD) has favorable outcomes with targeted therapy, early-stage prognosis remains influenced by pathological factors and central nervous system (CNS) recurrence....
3.
Akamine T, Wakasu S, Matsubara T, Yamaguchi M, Yamazaki K, Hamatake M, et al.
Ann Surg Oncol
. 2024 Dec;
PMID: 39681715
Background: Sublobar resection is the standard procedure for cT1N0 stage I non-small cell lung cancer (NSCLC) size ≤2 cm. However, its efficacy for high-risk pathologic stage I cases with a...
4.
Yutaka Y, Matsubara T, Tanaka S, Date H
Multimed Man Cardiothorac Surg
. 2024 Dec;
2024.
PMID: 39665536
Performing a posterior basal (S10) segmentectomy through a single port is challenging because of the dorsal location of the S10 segment in the lower lobe. The vessels and bronchi to...
5.
Kayawake H, Sakanoue I, Tanaka S, Yutaka Y, Nishino Y, Matsumoto A, et al.
Gen Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39652304
Objectives: Generally, HLA matching between donors and recipients is not performed in lung transplantation (LTx). Therefore, whether HLA mismatch between donors and recipients (D/R mismatch) influences postoperative outcomes after LTx...
6.
Nomura K, Takada K, Kinoshita F, Muto S, Matsubara T, Kouki Y, et al.
Int J Cancer
. 2024 Nov;
156(7):1480-1491.
PMID: 39569608
The expression of programmed cell death-ligand 1 (PD-L1) and mutation in epidermal growth factor receptor (EGFR) are biomarkers used for perioperative treatment of lung adenocarcinoma. However, the clinical significance of...
7.
Matsubara T, Uda C, Sano C, Ohta R
Cureus
. 2024 May;
16(4):e58940.
PMID: 38800308
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a type of seronegative arthritis characterized by a favorable prognosis (Remitting), absence of rheumatoid factor (Seronegative), symmetry (Symmetrical), and synovitis...
8.
Hashinokuchi A, Matsubara T, Takenaka T, Yoshizumi T
Ann Surg Oncol
. 2024 Mar;
31(8):5092-5093.
PMID: 38494560
No abstract available.
9.
Hashinokuchi A, Matsubara T, Ono Y, Shunichi S, Matsudo K, Nagano T, et al.
Ann Surg Oncol
. 2024 Mar;
31(7):4822-4829.
PMID: 38461192
Background: Glutathione peroxidase 2 (GPX2) is an antioxidant enzyme with an important role in tumor progression in various cancers. However, the clinical significance of GPX2 in lung adenocarcinoma has not...
10.
Katsumata S, Shimokawa M, Hamada A, Haratake N, Nomura K, Fujino K, et al.
Eur J Cancer
. 2024 Feb;
201:113951.
PMID: 38417299
Objectives: To clarify the impact of central nervous system (CNS) metastasis on performance status (PS) at relapse, on subsequent treatment(s), and on survival of patients with lung adenocarcinoma harboring common...